Pradžia › Manija › Kalifornija
Manija klinikiniai tyrimai Kalifornija
5 tyrimai dėl Manija ieško dalyvių vietose Kalifornija.
Miestai Kalifornija
Oficialus tyrimo tekstas (anglų kalba)
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
- Neurocrine Clinical Site, Cerritos
- Neurocrine Clinical Site, Garden Grove
- Neurocrine Clinical Site, San Diego
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-29 · NCT07288320A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Proscience Research Group, Culver City
- Clinical Innovations, Inc. dba CITrials, Riverside
- Collaborative Neuroscience Research, LLC, Torrance
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06951711A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
- Advanced Research Center Inc., Anaheim
- CITrials, Bellflower
- Local Institution - 0014, Cerritos
- ir dar 3
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-22 · NCT06951698A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- Advanced Research Center Inc., Anaheim
- Clinical Innovations, Inc. dba CITrials, Bellflower
- Local Institution - 0044, Cerritos
- ir dar 10
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-14 · NCT06929273A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Clinical Innovations, Inc. dba CITrials, Bellflower
- Inland Psychiatric Medical Group., Chino
- Proscience Research Group, Culver City
- ir dar 4
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-06-23 · NCT07140913Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.